Refine by
Sleep Better Articles & Analysis: Older
16 news found
In today’s digital age and remote work environments, the boundaries between work and personal life have become increasingly blurred. With the prevalence in our lives of smartphones, tablets, and laptops, employees are spending more time in front of screens than ever before. As executives, it’s our responsibility to recognize the impact of excessive screen time on our ...
Have you heard of the sensory phenomenon known as ASMR for sleep? ASMR stands for autonomous sensory meridian response, a condition, experience, or phenomenon that helps you fall asleep. As a form of parasthesia (a group or series of sensations felt in the skin), ASMR is perceived as a pleasant experience that is characterized by a tingling sensation in the neck and scalp areas that are ...
What is Newborn Snoring? Oftentimes, newborns breathe noisily when they sleep. It may be caused due to extra mucus or dryness in their tiny nasal passages. However, if you notice your newborn baby actually snoring on a regular basis, consult with a doctor. If your snoring is causing issues with your partner or his/her snoring is irritating you at night, it is important that you seek timely ...
Our first Clinical Study at OBI already achieved a 20% reduction in seizures……..we believe we can do better with our more concentrated formula. Nutraceutical: Our e-commerce site is live now and Mentanine and Omega-3 Index Booster (high concentration of DHA/EPA) have been produced in California and are available for sale in the US and for export. ...
Rose - Breathing I have to say that during these stressful times I am sleeping well and waking up more refreshed. I usually have a lot of “clearing” of my lungs in the mornings, but the SoeMac has really helped with that. I am sleeping more deeply and am actually giving my lungs a rest. Peter - Breathing I have used SoeMac for over 3 years, and it ...
BySoeMac
“On the clinical front, we announced that our BETTER SLEEP clinical trial achieved a statistically significant mean reduction in the Apnea Hypopnea Index (AHI) from baseline to six months post implantation for the entire cohort as well as for the subgroup of patients with Complete Concentric Collapse (CCC) of the soft palate. ...
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference ...
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Loïc Moreau will join Nyxoah as CFO as of January 1, 2022. ...
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Stifel 2021 Virtual Healthcare Conference on Monday, ...
Signifier Medical Technologies Ltd, an innovator in the sleep-disordered breathing market, announced today that it has hit the 50,000 therapy session milestone with its innovative eXciteOSA® sleep device. ...
DEKRA attributed the updated Genio® therapeutic indication to the BETTER SLEEP study data presented by the Company, concluding that “the effectiveness results and safety profile for both CCC and non-CCC patients are comparable”. ...
About BETTER SLEEP Trial BilatEral Hypoglossal Nerve StimulaTion for TreatmEnt of ObstRuctive SLEEP Apnoea, or BETTER SLEEP, is a multicenter, prospective, open-label, two-group clinical trial, designed to assess the safety and performance of the Genio® system for the treatment of OSA in adult patients with ...
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Cantor 2021 Global Healthcare Conference on Tuesday, ...
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, and Fabian Suarez, Chief Financial Officer, will participate at the Baird 2021 ...
Richard Lewis, leading author of this publication and Principal Investigator of the BETTER SLEEP study commented: “This case demonstrates successful control of obstructive sleep apnea in a patient with Complete Concentric Collapse (CCC) of the retropalatal airway. Whilst the final results of the BETTER ...
Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA), today announces the participation of its management team in the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021. ...